Adaptive Biotechnologies Corp (ADPT) Insider Ownership

Historic Ownership Trends

Over the 90-day window ending December 12, 2025, Adaptive Biotechnologies's three dominant insider ownership positions are held by CEO And Chairman Chad M Robins (2.71Mn shares), Chief Scientific Officer Harlan S Robins (1.23Mn shares), Chief Commercial Officer And Mrd Susan Bobulsky (347.24K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
David E. Goel 12,310,594 17 Feb, 2021
Chad M Robins CEO And Chairman 2,709,241 01 Dec, 2025
Harlan S Robins Chief Scientific Officer 1,232,312 05 Dec, 2025
Julie Rubinstein President And COO 588,249 06 Mar, 2025
Tycho Peterson Chief Financial Officer 531,553 06 Mar, 2024
Susan Bobulsky Chief Commercial Officer And Mrd 347,238 06 Mar, 2025
Francis Lo Chief People Officer 332,846 06 Mar, 2025
Sharon Benzeno Chief Commercial Ofc Imm Med 296,791 08 Dec, 2025
Peter M Neupert 224,690 12 Mar, 2025
Kyle Piskel Chief Financial Officer 216,637 02 Dec, 2025
Nitin Sood Chief Commercial Officer And Mrd 214,808 08 Aug, 2023
R Mark Adams Chief Operating Officer 175,361 12 Apr, 2023
Stacy L Taylor SVP And General Counsel 139,365 23 Aug, 2024
Katey Einterz Owen 72,629 06 Mar, 2025
Michael J Pellini 69,690 06 Mar, 2025
Robert Hershberg 46,722 12 Dec, 2025
Henning Thorsen SVP And Commercial Operations 29,061 19 May, 2021
Leslie Trigg 25,907 08 Mar, 2023
Kevin T Conroy 22,968 08 Mar, 2023
Chad M Cohen Chief Financial Officer 21,604 23 Dec, 2021
Lance Baldo Chief Medical Officer 17,171 10 Mar, 2022
Michelle Renee Griffin 15,394 17 Mar, 2025
Nancy Louise Hill EVP And Operations & Program Mana 10,000 21 Jan, 2021
Jyoti Palaniappan SVP And Diagnostics And T Detect 9,158 19 Jul, 2021
Eric Dobmeier 1,504 17 Feb, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
10 Dec, 2025 Robert Hershberg Common Stock D 22,968 $16.00 46,722 D S
04 Dec, 2025 Sharon Benzeno Common Stock A 4,290 $12.14 301,081 D M
04 Dec, 2025 Sharon Benzeno Common Stock A 4,157 $8.46 305,238 D M
04 Dec, 2025 Sharon Benzeno Common Stock A 4,157 $3.99 309,395 D M
04 Dec, 2025 Sharon Benzeno Common Stock D 12,604 $16.85 296,791 D S
03 Dec, 2025 Harlan S Robins Common Stock D 27,212 $18.61 1,242,312 D S
04 Dec, 2025 Harlan S Robins Common Stock D 10,000 $16.61 1,232,312 D S
28 Nov, 2025 Kyle Piskel Common Stock A 11,980 $6.55 281,323 D M
28 Nov, 2025 Kyle Piskel Common Stock A 3,750 $7.80 285,073 D M
28 Nov, 2025 Kyle Piskel Common Stock A 94,384 $12.14 379,457 D M
28 Nov, 2025 Kyle Piskel Common Stock D 162,820 $19.50 216,637 D S
26 Nov, 2025 Chad M Robins Common Stock D 35,736 $19.68 2,834,239 D S
01 Dec, 2025 Chad M Robins Common Stock D 124,998 $18.94 2,709,241 D S
20 Nov, 2025 Sharon Benzeno Common Stock A 133,032 $8.46 525,755 D M
20 Nov, 2025 Sharon Benzeno Common Stock A 68,961 $12.14 594,716 D M
20 Nov, 2025 Sharon Benzeno Common Stock D 297,925 $16.54 296,791 D S
21 Nov, 2025 Sharon Benzeno Common Stock A 834 $6.27 297,625 D M
21 Nov, 2025 Sharon Benzeno Common Stock A 20,834 $6.55 318,459 D M
21 Nov, 2025 Sharon Benzeno Common Stock A 49,480 $6.55 367,939 D M
21 Nov, 2025 Sharon Benzeno Common Stock A 34,375 $7.27 402,314 D M